Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany.
Identifieur interne : 000169 ( Main/Exploration ); précédent : 000168; suivant : 000170Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany.
Auteurs : Andi Krumbholz [Allemagne] ; Jeannette Lange ; Ralf Dürrwald ; Mario Walther ; Thomas H. Müller ; Detlef Kühnel ; Peter Wutzler ; Andreas Sauerbrei ; Roland ZellSource :
- Medical microbiology and immunology [ 1432-1831 ] ; 2014.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Allemagne (épidémiologie), Animaux (MeSH), Anticorps antiviraux (immunologie), Anticorps antiviraux (sang), Antigènes viraux (immunologie), Femelle (MeSH), Grippe humaine (immunologie), Grippe humaine (transmission), Grippe humaine (épidémiologie), Humains (MeSH), Infections à Orthomyxoviridae (médecine vétérinaire), Jeune adulte (MeSH), Maladies des porcs (virologie), Mâle (MeSH), Odds ratio (MeSH), Prévalence (MeSH), Suidae (MeSH), Tests d'inhibition de l'hémagglutination (MeSH), Virus de la grippe A (immunologie), Études séroépidémiologiques (MeSH).
- MESH :
- immunologie : Anticorps antiviraux, Antigènes viraux, Grippe humaine, Virus de la grippe A.
- médecine vétérinaire : Infections à Orthomyxoviridae.
- sang : Anticorps antiviraux.
- virologie : Maladies des porcs.
- épidémiologie : Allemagne, Grippe humaine.
- Adolescent, Adulte, Adulte d'âge moyen, Animaux, Femelle, Humains, Jeune adulte, Mâle, Odds ratio, Prévalence, Suidae, Tests d'inhibition de l'hémagglutination, Études séroépidémiologiques.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Animals (MeSH), Antibodies, Viral (blood), Antibodies, Viral (immunology), Antigens, Viral (immunology), Female (MeSH), Germany (epidemiology), Hemagglutination Inhibition Tests (MeSH), Humans (MeSH), Influenza A virus (immunology), Influenza, Human (epidemiology), Influenza, Human (immunology), Influenza, Human (transmission), Male (MeSH), Middle Aged (MeSH), Odds Ratio (MeSH), Orthomyxoviridae Infections (veterinary), Prevalence (MeSH), Seroepidemiologic Studies (MeSH), Swine (MeSH), Swine Diseases (virology), Young Adult (MeSH).
- MESH :
- chemical , blood : Antibodies, Viral.
- chemical , immunology : Antibodies, Viral, Antigens, Viral.
- geographic , epidemiology : Germany.
- epidemiology : Influenza, Human.
- immunology : Influenza A virus, Influenza, Human.
- transmission : Influenza, Human.
- veterinary : Orthomyxoviridae Infections.
- virology : Swine Diseases.
- Adolescent, Adult, Animals, Female, Hemagglutination Inhibition Tests, Humans, Male, Middle Aged, Odds Ratio, Prevalence, Seroepidemiologic Studies, Swine, Young Adult.
Abstract
The risk of zoonotic human infection caused by European porcine influenza virus strains was estimated in German regions with a high pig density. Sera from 622 healthy volunteers were collected between April 2009 and November 2011, mainly in Westphalia and western Lower Saxony. These included 362 subjects with occupational contact to pigs and 260 blood donors without any direct exposition to pigs. Samples were analysed by the haemagglutination inhibition (HI) assay against a panel of six swine viruses of subtypes avian-like H1N1 and human-like H3N2 as well as against human H1N1 and H3N2 viruses including the pandemic H1N1 strain of 2009. Reciprocal HI titres ≥20 were quoted as seroreactive. Compared to the control group, a significantly higher proportion of subjects with direct contact to pigs exhibited seroreactivity against porcine antigens of the avian-like H1N1 (37.0 %/7.7 %), the human-like H3N2 (59.7 %/43.1 %), the pandemic H1N1 strain of 2009 (51.7 %/26.5 %) and against a historic seasonal H3N2 strain that is closely related antigenetically to currently circulating human-like H3N2 viruses of European pigs (57.5 %/36.5 %). This trend was also observed when a reciprocal HI titre ≥40 was chosen as cut-off. Particularly, in younger subjects, the differences in seroreactivity against porcine strains between the exposed and non-exposed group were significant. The data indicate a higher risk of infection in the exposed individuals.
DOI: 10.1007/s00430-013-0309-y
PubMed: 24013183
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany.</title><author><name sortKey="Krumbholz, Andi" sort="Krumbholz, Andi" uniqKey="Krumbholz A" first="Andi" last="Krumbholz">Andi Krumbholz</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Infection Medicine, Christian Albrecht University of Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Brunswiker Strasse 4, 24105, Kiel, Germany, krumbholz@infmed.uni-kiel.de.</nlm:affiliation><country wicri:rule="url">Allemagne</country><wicri:regionArea>Institute for Infection Medicine, Christian Albrecht University of Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Brunswiker Strasse 4, 24105, Kiel, Germany</wicri:regionArea><wicri:noRegion>Germany</wicri:noRegion><wicri:noRegion>Germany</wicri:noRegion><wicri:noRegion>Germany</wicri:noRegion></affiliation></author><author><name sortKey="Lange, Jeannette" sort="Lange, Jeannette" uniqKey="Lange J" first="Jeannette" last="Lange">Jeannette Lange</name></author><author><name sortKey="Durrwald, Ralf" sort="Durrwald, Ralf" uniqKey="Durrwald R" first="Ralf" last="Dürrwald">Ralf Dürrwald</name></author><author><name sortKey="Walther, Mario" sort="Walther, Mario" uniqKey="Walther M" first="Mario" last="Walther">Mario Walther</name></author><author><name sortKey="Muller, Thomas H" sort="Muller, Thomas H" uniqKey="Muller T" first="Thomas H" last="Müller">Thomas H. Müller</name></author><author><name sortKey="Kuhnel, Detlef" sort="Kuhnel, Detlef" uniqKey="Kuhnel D" first="Detlef" last="Kühnel">Detlef Kühnel</name></author><author><name sortKey="Wutzler, Peter" sort="Wutzler, Peter" uniqKey="Wutzler P" first="Peter" last="Wutzler">Peter Wutzler</name></author><author><name sortKey="Sauerbrei, Andreas" sort="Sauerbrei, Andreas" uniqKey="Sauerbrei A" first="Andreas" last="Sauerbrei">Andreas Sauerbrei</name></author><author><name sortKey="Zell, Roland" sort="Zell, Roland" uniqKey="Zell R" first="Roland" last="Zell">Roland Zell</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24013183</idno><idno type="pmid">24013183</idno><idno type="doi">10.1007/s00430-013-0309-y</idno><idno type="wicri:Area/Main/Corpus">000190</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000190</idno><idno type="wicri:Area/Main/Curation">000190</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000190</idno><idno type="wicri:Area/Main/Exploration">000190</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany.</title><author><name sortKey="Krumbholz, Andi" sort="Krumbholz, Andi" uniqKey="Krumbholz A" first="Andi" last="Krumbholz">Andi Krumbholz</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Infection Medicine, Christian Albrecht University of Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Brunswiker Strasse 4, 24105, Kiel, Germany, krumbholz@infmed.uni-kiel.de.</nlm:affiliation><country wicri:rule="url">Allemagne</country><wicri:regionArea>Institute for Infection Medicine, Christian Albrecht University of Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Brunswiker Strasse 4, 24105, Kiel, Germany</wicri:regionArea><wicri:noRegion>Germany</wicri:noRegion><wicri:noRegion>Germany</wicri:noRegion><wicri:noRegion>Germany</wicri:noRegion></affiliation></author><author><name sortKey="Lange, Jeannette" sort="Lange, Jeannette" uniqKey="Lange J" first="Jeannette" last="Lange">Jeannette Lange</name></author><author><name sortKey="Durrwald, Ralf" sort="Durrwald, Ralf" uniqKey="Durrwald R" first="Ralf" last="Dürrwald">Ralf Dürrwald</name></author><author><name sortKey="Walther, Mario" sort="Walther, Mario" uniqKey="Walther M" first="Mario" last="Walther">Mario Walther</name></author><author><name sortKey="Muller, Thomas H" sort="Muller, Thomas H" uniqKey="Muller T" first="Thomas H" last="Müller">Thomas H. Müller</name></author><author><name sortKey="Kuhnel, Detlef" sort="Kuhnel, Detlef" uniqKey="Kuhnel D" first="Detlef" last="Kühnel">Detlef Kühnel</name></author><author><name sortKey="Wutzler, Peter" sort="Wutzler, Peter" uniqKey="Wutzler P" first="Peter" last="Wutzler">Peter Wutzler</name></author><author><name sortKey="Sauerbrei, Andreas" sort="Sauerbrei, Andreas" uniqKey="Sauerbrei A" first="Andreas" last="Sauerbrei">Andreas Sauerbrei</name></author><author><name sortKey="Zell, Roland" sort="Zell, Roland" uniqKey="Zell R" first="Roland" last="Zell">Roland Zell</name></author></analytic><series><title level="j">Medical microbiology and immunology</title><idno type="eISSN">1432-1831</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Animals (MeSH)</term><term>Antibodies, Viral (blood)</term><term>Antibodies, Viral (immunology)</term><term>Antigens, Viral (immunology)</term><term>Female (MeSH)</term><term>Germany (epidemiology)</term><term>Hemagglutination Inhibition Tests (MeSH)</term><term>Humans (MeSH)</term><term>Influenza A virus (immunology)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (transmission)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Odds Ratio (MeSH)</term><term>Orthomyxoviridae Infections (veterinary)</term><term>Prevalence (MeSH)</term><term>Seroepidemiologic Studies (MeSH)</term><term>Swine (MeSH)</term><term>Swine Diseases (virology)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Allemagne (épidémiologie)</term><term>Animaux (MeSH)</term><term>Anticorps antiviraux (immunologie)</term><term>Anticorps antiviraux (sang)</term><term>Antigènes viraux (immunologie)</term><term>Femelle (MeSH)</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (transmission)</term><term>Grippe humaine (épidémiologie)</term><term>Humains (MeSH)</term><term>Infections à Orthomyxoviridae (médecine vétérinaire)</term><term>Jeune adulte (MeSH)</term><term>Maladies des porcs (virologie)</term><term>Mâle (MeSH)</term><term>Odds ratio (MeSH)</term><term>Prévalence (MeSH)</term><term>Suidae (MeSH)</term><term>Tests d'inhibition de l'hémagglutination (MeSH)</term><term>Virus de la grippe A (immunologie)</term><term>Études séroépidémiologiques (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term><term>Antigens, Viral</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term><term>Antigènes viraux</term><term>Grippe humaine</term><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="médecine vétérinaire" xml:lang="fr"><term>Infections à Orthomyxoviridae</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="veterinary" xml:lang="en"><term>Orthomyxoviridae Infections</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Maladies des porcs</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Swine Diseases</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Animals</term><term>Female</term><term>Hemagglutination Inhibition Tests</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Odds Ratio</term><term>Prevalence</term><term>Seroepidemiologic Studies</term><term>Swine</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Odds ratio</term><term>Prévalence</term><term>Suidae</term><term>Tests d'inhibition de l'hémagglutination</term><term>Études séroépidémiologiques</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The risk of zoonotic human infection caused by European porcine influenza virus strains was estimated in German regions with a high pig density. Sera from 622 healthy volunteers were collected between April 2009 and November 2011, mainly in Westphalia and western Lower Saxony. These included 362 subjects with occupational contact to pigs and 260 blood donors without any direct exposition to pigs. Samples were analysed by the haemagglutination inhibition (HI) assay against a panel of six swine viruses of subtypes avian-like H1N1 and human-like H3N2 as well as against human H1N1 and H3N2 viruses including the pandemic H1N1 strain of 2009. Reciprocal HI titres ≥20 were quoted as seroreactive. Compared to the control group, a significantly higher proportion of subjects with direct contact to pigs exhibited seroreactivity against porcine antigens of the avian-like H1N1 (37.0 %/7.7 %), the human-like H3N2 (59.7 %/43.1 %), the pandemic H1N1 strain of 2009 (51.7 %/26.5 %) and against a historic seasonal H3N2 strain that is closely related antigenetically to currently circulating human-like H3N2 viruses of European pigs (57.5 %/36.5 %). This trend was also observed when a reciprocal HI titre ≥40 was chosen as cut-off. Particularly, in younger subjects, the differences in seroreactivity against porcine strains between the exposed and non-exposed group were significant. The data indicate a higher risk of infection in the exposed individuals.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24013183</PMID><DateCompleted><Year>2014</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1831</ISSN><JournalIssue CitedMedium="Internet"><Volume>203</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Medical microbiology and immunology</Title><ISOAbbreviation>Med. Microbiol. Immunol.</ISOAbbreviation></Journal><ArticleTitle>Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany.</ArticleTitle><Pagination><MedlinePgn>13-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00430-013-0309-y</ELocationID><Abstract><AbstractText>The risk of zoonotic human infection caused by European porcine influenza virus strains was estimated in German regions with a high pig density. Sera from 622 healthy volunteers were collected between April 2009 and November 2011, mainly in Westphalia and western Lower Saxony. These included 362 subjects with occupational contact to pigs and 260 blood donors without any direct exposition to pigs. Samples were analysed by the haemagglutination inhibition (HI) assay against a panel of six swine viruses of subtypes avian-like H1N1 and human-like H3N2 as well as against human H1N1 and H3N2 viruses including the pandemic H1N1 strain of 2009. Reciprocal HI titres ≥20 were quoted as seroreactive. Compared to the control group, a significantly higher proportion of subjects with direct contact to pigs exhibited seroreactivity against porcine antigens of the avian-like H1N1 (37.0 %/7.7 %), the human-like H3N2 (59.7 %/43.1 %), the pandemic H1N1 strain of 2009 (51.7 %/26.5 %) and against a historic seasonal H3N2 strain that is closely related antigenetically to currently circulating human-like H3N2 viruses of European pigs (57.5 %/36.5 %). This trend was also observed when a reciprocal HI titre ≥40 was chosen as cut-off. Particularly, in younger subjects, the differences in seroreactivity against porcine strains between the exposed and non-exposed group were significant. The data indicate a higher risk of infection in the exposed individuals.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krumbholz</LastName><ForeName>Andi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Infection Medicine, Christian Albrecht University of Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Brunswiker Strasse 4, 24105, Kiel, Germany, krumbholz@infmed.uni-kiel.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Jeannette</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Dürrwald</LastName><ForeName>Ralf</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Walther</LastName><ForeName>Mario</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Müller</LastName><ForeName>Thomas H</ForeName><Initials>TH</Initials></Author><Author ValidYN="Y"><LastName>Kühnel</LastName><ForeName>Detlef</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Wutzler</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Sauerbrei</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zell</LastName><ForeName>Roland</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Med Microbiol Immunol</MedlineTA><NlmUniqueID>0314524</NlmUniqueID><ISSNLinking>0300-8584</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006385" MajorTopicYN="N">Hemagglutination Inhibition Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013553" MajorTopicYN="N">Swine Diseases</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>03</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>08</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24013183</ArticleId><ArticleId IdType="doi">10.1007/s00430-013-0309-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>PLoS One. 2013;8(2):e57576</Citation><ArticleIdList><ArticleId IdType="pubmed">23469029</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Feb 15;197 Suppl 1:S29-33</Citation><ArticleIdList><ArticleId IdType="pubmed">18269325</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Jun 22;30(30):4419-34</Citation><ArticleIdList><ArticleId IdType="pubmed">22537992</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 2013;370:29-55</Citation><ArticleIdList><ArticleId IdType="pubmed">23011571</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Microbiol Immunol. 2012 Aug;201(3):297-302</Citation><ArticleIdList><ArticleId IdType="pubmed">22350187</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2008 May;2(3):99-105</Citation><ArticleIdList><ArticleId IdType="pubmed">19453469</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2011 May;92(Pt 5):1184-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21307227</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2013 May 16;368(20):1888-97</Citation><ArticleIdList><ArticleId IdType="pubmed">23577628</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Jun 18;360(25):2616-25</Citation><ArticleIdList><ArticleId IdType="pubmed">19423871</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2011 Jun;17 (6):1049-52</Citation><ArticleIdList><ArticleId IdType="pubmed">21749767</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2010 Jun;16(6):1029-30</Citation><ArticleIdList><ArticleId IdType="pubmed">20507767</ArticleId></ArticleIdList></Reference><Reference><Citation>Vet Microbiol. 2011 May 5;149(3-4):472-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21208754</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1994 Oct;204(1):453-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8091678</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2010 Sep;82(9):1617-25</Citation><ArticleIdList><ArticleId IdType="pubmed">20648619</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2004 Jul;103(1-2):133-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15163501</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Virol. 2003 Apr;148(4):793-802</Citation><ArticleIdList><ArticleId IdType="pubmed">12664301</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Microbiol Immunol. 2013 Feb;202(1):87-94</Citation><ArticleIdList><ArticleId IdType="pubmed">22684725</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Microbiol Immunol. 2013 Apr;202(2):125-30</Citation><ArticleIdList><ArticleId IdType="pubmed">22986732</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2009 Feb 19;14(7):null</Citation><ArticleIdList><ArticleId IdType="pubmed">19232229</ArticleId></ArticleIdList></Reference><Reference><Citation>MBio. 2011 Aug 30;2(5):null</Citation><ArticleIdList><ArticleId IdType="pubmed">21878571</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2002 May 10;85(2):199-210</Citation><ArticleIdList><ArticleId IdType="pubmed">12034486</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2001 Apr 10;282(2):301-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11289812</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2006 Jan 1;42(1):14-20</Citation><ArticleIdList><ArticleId IdType="pubmed">16323086</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2012 Aug;93(Pt 8):1658-63</Citation><ArticleIdList><ArticleId IdType="pubmed">22622326</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2011 Mar;17(3):403-11</Citation><ArticleIdList><ArticleId IdType="pubmed">21392430</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4269-74</Citation><ArticleIdList><ArticleId IdType="pubmed">22371588</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2012 Jan 12;17(2):null</Citation><ArticleIdList><ArticleId IdType="pubmed">22264864</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2009 Feb 19;14(7):null</Citation><ArticleIdList><ArticleId IdType="pubmed">19232228</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Virol. 2013 Jan;158(1):39-53</Citation><ArticleIdList><ArticleId IdType="pubmed">22935945</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2001 Jun;82(Pt 6):1397-406</Citation><ArticleIdList><ArticleId IdType="pubmed">11369884</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hyg (Lond). 1972 Dec;70(4):767-77</Citation><ArticleIdList><ArticleId IdType="pubmed">4509641</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2007 Apr 15;44(8):1084-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17366454</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Microbiol Immunol. 2013 Dec;202(6):417-24</Citation><ArticleIdList><ArticleId IdType="pubmed">23812435</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country></list><tree><noCountry><name sortKey="Durrwald, Ralf" sort="Durrwald, Ralf" uniqKey="Durrwald R" first="Ralf" last="Dürrwald">Ralf Dürrwald</name><name sortKey="Kuhnel, Detlef" sort="Kuhnel, Detlef" uniqKey="Kuhnel D" first="Detlef" last="Kühnel">Detlef Kühnel</name><name sortKey="Lange, Jeannette" sort="Lange, Jeannette" uniqKey="Lange J" first="Jeannette" last="Lange">Jeannette Lange</name><name sortKey="Muller, Thomas H" sort="Muller, Thomas H" uniqKey="Muller T" first="Thomas H" last="Müller">Thomas H. Müller</name><name sortKey="Sauerbrei, Andreas" sort="Sauerbrei, Andreas" uniqKey="Sauerbrei A" first="Andreas" last="Sauerbrei">Andreas Sauerbrei</name><name sortKey="Walther, Mario" sort="Walther, Mario" uniqKey="Walther M" first="Mario" last="Walther">Mario Walther</name><name sortKey="Wutzler, Peter" sort="Wutzler, Peter" uniqKey="Wutzler P" first="Peter" last="Wutzler">Peter Wutzler</name><name sortKey="Zell, Roland" sort="Zell, Roland" uniqKey="Zell R" first="Roland" last="Zell">Roland Zell</name></noCountry><country name="Allemagne"><noRegion><name sortKey="Krumbholz, Andi" sort="Krumbholz, Andi" uniqKey="Krumbholz A" first="Andi" last="Krumbholz">Andi Krumbholz</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000169 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000169 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeAllemagneV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24013183
|texte= Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24013183" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV4
| This area was generated with Dilib version V0.6.35. |  |